Ampio shares rise on bullish online report

(Reuters) – Shares of Ampio Pharmaceuticals Inc rose as much as 39 percent on Friday after an investment website said it expects Ampio to be the next “blockbuster” stock. With 3 blockbuster drugs, Ampio is all primed up for loads of news about clinical trials, the FDA and potential partners, Seeking Alpha said in a report published on Friday. Ampio’s drug to treat premature ejaculation is in a late-stage study, while its diabetes related eye disease and anti-inflammation drugs have completed mid-stage trials. …